BIOA
BioAge Labs Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.72
-1.17 ▼ -5.86%
🌙 3월 13일 7:22 PM ET (한국 3/14 08:22)
$18.97
+0.25 ▲ +1.34%
| Index | RUT | P/E | - | EPS (ttm) | -2.11 | Insider Own | 30.51% | Shs Outstand | 0.04B | Perf Week | -7.74% |
| Market Cap | 0.78B | Forward P/E | - | EPS next Y | -21.94% | Insider Trans | -2.82% | Shs Float | 0.03B | Perf Month | -6.35% |
| Enterprise Value | 0.50B | PEG | - | EPS next Q | -0.74 | Inst Own | 35.72% | Short Float | 4.4% | Perf Quarter | 47.63% |
| Income | -0.08B | P/S | 132.03 | EPS this Y | 65.81% | Inst Trans | 6.38% | Short Ratio | 1.87 | Perf Half Y | 281.26% |
| Sales | 0.01B | P/B | 2.42 | EPS next 5Y | 25.62% | ROA | -23.59% | Short Interest | 1.28M | Perf YTD | 41.5% |
| Book/sh | 7.74 | P/C | 2.74 | EPS past 3/5Y | -30.62% - | ROE | -25.64% | 52W High | -22% ($24.00) | Perf Year | 345.71% |
| Cash/sh | 6.84 | P/FCF | - | Sales past 3/5Y | - | ROIC | -27.08% | 52W Low | 550% ($2.88) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -1.89% | Gross Margin | 96.77% | Volatility(W/M) | 8.7% 7.49% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 84.96 | Sales Y/Y TTM | - | Oper. Margin | -1516.29% | ATR (14) | 1.54 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 11.87 | EPS Q/Q | 17.81% | Profit Margin | -1280.9% | RSI (14) | 41.29 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 11.87 | Sales Q/Q | - | SMA20 | -9.21% ($20.62) | Beta | 1.49 | Target Price | $54 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 11000000 | SMA50 | -3.36% ($19.37) | Rel Volume | 0.94 | Prev Close | $19.89 |
| Employees | 64 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 4.04% 164.18% | SMA200 | 94.91% ($9.6) | Avg Volume(3M) | 0.68M | Price | $18.72 |
| IPO | 2024/9/26 | Option/Short | Yes/Yes | Trades | 7808 | Volume | 644,500 | Change | -5.86% |
뉴스 로딩 중...